Literature DB >> 25877012

AACE/ACE comprehensive diabetes management algorithm 2015.

Alan J Garber, Martin J Abrahamson, Joshua I Barzilay, Lawrence Blonde, Zachary T Bloomgarden, Michael A Bush, Samuel Dagogo-Jack, Michael B Davidson, Daniel Einhorn, Jeffrey R Garber, W Timothy Garvey, George Grunberger, Yehuda Handelsman, Irl B Hirsch, Paul S Jellinger, Janet B McGill, Jeffrey I Mechanick, Paul D Rosenblit, Guillermo Umpierrez, Michael H Davidson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25877012     DOI: 10.4158/EP15693.CS

Source DB:  PubMed          Journal:  Endocr Pract        ISSN: 1530-891X            Impact factor:   3.443


× No keyword cloud information.
  76 in total

Review 1.  Teneligliptin: a review in type 2 diabetes.

Authors:  Lesley J Scott
Journal:  Clin Drug Investig       Date:  2015-11       Impact factor: 2.859

2.  Challenging obesity: Patient, provider, and expert perspectives on the roles of available and emerging nonsurgical therapies.

Authors:  Caroline M Apovian; W Timothy Garvey; Donna H Ryan
Journal:  Obesity (Silver Spring)       Date:  2015-07       Impact factor: 5.002

3.  Intensive Treatment and Severe Hypoglycemia Among Adults With Type 2 Diabetes.

Authors:  Rozalina G McCoy; Kasia J Lipska; Xiaoxi Yao; Joseph S Ross; Victor M Montori; Nilay D Shah
Journal:  JAMA Intern Med       Date:  2016-07-01       Impact factor: 21.873

Review 4.  Sitagliptin: A Review in Type 2 Diabetes.

Authors:  Lesley J Scott
Journal:  Drugs       Date:  2017-02       Impact factor: 9.546

5.  Using Indirect Measures to Identify Geographic Hot Spots of Poor Glycemic Control: Cross-sectional Comparisons With an A1C Registry.

Authors:  David C Lee; Qun Jiang; Bahman P Tabaei; Brian Elbel; Christian A Koziatek; Kevin J Konty; Winfred Y Wu
Journal:  Diabetes Care       Date:  2018-04-24       Impact factor: 19.112

6.  American association of clinical endocrinologists and american college of endocrinology - clinical practice guidelines for developing a diabetes mellitus comprehensive care plan - 2015.

Authors:  Yehuda Handelsman; Zachary T Bloomgarden; George Grunberger; Guillermo Umpierrez; Robert S Zimmerman; Timothy S Bailey; Lawrence Blonde; George A Bray; A Jay Cohen; Samuel Dagogo-Jack; Jaime A Davidson; Daniel Einhorn; Om P Ganda; Alan J Garber; W Timothy Garvey; Robert R Henry; Irl B Hirsch; Edward S Horton; Daniel L Hurley; Paul S Jellinger; Lois Jovanovič; Harold E Lebovitz; Derek LeRoith; Philip Levy; Janet B McGill; Jeffrey I Mechanick; Jorge H Mestman; Etie S Moghissi; Eric A Orzeck; Rachel Pessah-Pollack; Paul D Rosenblit; Aaron I Vinik; Kathleen Wyne; Farhad Zangeneh
Journal:  Endocr Pract       Date:  2015-04       Impact factor: 3.443

7.  Development and Validation of HealthImpact: An Incident Diabetes Prediction Model Based on Administrative Data.

Authors:  Rozalina G McCoy; Vijay S Nori; Steven A Smith; Christopher A Hane
Journal:  Health Serv Res       Date:  2016-02-21       Impact factor: 3.402

Review 8.  Clinical Pharmacokinetics and Pharmacodynamics of Insulin Glargine 300 U/mL.

Authors:  Jennifer N Clements; Tiffaney Threatt; Eileen Ward; Kayce M Shealy
Journal:  Clin Pharmacokinet       Date:  2017-05       Impact factor: 6.447

Review 9.  Empagliflozin/Linagliptin: A Review in Type 2 Diabetes.

Authors:  Esther S Kim; Emma D Deeks
Journal:  Drugs       Date:  2015-09       Impact factor: 9.546

Review 10.  Cancer, obesity, diabetes, and antidiabetic drugs: is the fog clearing?

Authors:  Adi J Klil-Drori; Laurent Azoulay; Michael N Pollak
Journal:  Nat Rev Clin Oncol       Date:  2016-08-09       Impact factor: 66.675

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.